Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy

Met is a receptor tyrosine kinase that promotes cancer progression. In addition, Met has been implicated in resistance of tumors to various targeted therapies such as EGFR inhibitors in lung cancers, and has been prioritized as a key molecular target for cancer therapy. However, the underlying mecha...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncogene
Hlavní autoři: Kim, Bogyou, Wang, Shangzi, Lee, Ji Min, Jeong, Yunju, Ahn, TaeJin, Son, Dae-Soon, Park, Hye Won, Yoo, Hyeon-seok, Song, Yun-Jeong, Lee, Eunjin, Oh, Young Mi, Lee, Saet Byoul, Choi, Jaehyun, Murray, Joseph C, Zhou, Yan, Song, Paul H, Kim, Kyung-Ah, Weiner, Louis M
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300291/
https://ncbi.nlm.nih.gov/pubmed/24662823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2014.51
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky